The 30-Second Answer
Type I collagen is the strong, load-bearing collagen that makes up roughly 80–85% of the collagen in adult skin. Type III collagen is the finer, softer, more flexible collagen associated with young skin and the early stage of wound repair, making up about 10–20% of adult dermal collagen. In export OEM today, most "collagen" requests are really requests for recombinant (fermentation-derived) collagen, because it is animal-free, traceable, and carries a lower pathogen and sensitization risk than bovine, porcine, or marine-extracted collagen.
If you are developing a cosmetic serum, cream, sheet mask, or freeze-dried powder, your product stays in the cosmetic lane: the collagen functions on the surface as a water-binding, film-forming, comfort-improving ingredient, and your claims must be cosmetic appearance language (helps skin look smoother, feel firmer, feel more hydrated). If you want an injectable or a wound-contacting product with biological or medical claims, that is a completely different regulatory pathway (a Class III injectable or a Class II sterile dressing), built around registered medical devices — not a cosmetic project.
This guide explains the difference between Type I and Type III, the three official categories of recombinant collagen used in China, how the ingredient is named on labels, what formulations are practical, and how to stay compliant in your target market.
Why Buyers Are Asking About Collagen Right Now
Collagen is one of the most recognized skin-care words in the world, which is both the opportunity and the problem. Consumers trust the word and search for it, but the market is crowded with vague "collagen" products that never specify the type, the source, the molecular form, or the concentration. For a private-label brand, that vagueness is your opening: a product that clearly states its collagen type, source, and form is easier to merchandise and easier to defend to a regulator.
The broader commercial shift is the move from animal extraction to synthetic biology. Instead of harvesting collagen from cow hide, pig tissue, fish skin, or jellyfish, producers now insert a human collagen gene into a host organism (commonly E. coli or the yeast Pichia pastoris), ferment it like a biotech active, and purify the resulting protein. China's recombinant collagen market has grown rapidly on the back of this technology, and a national medical industry standard (YY/T 1888-2023) now defines the terminology, which makes specification conversations much cleaner than they were a few years ago.
Type I vs Type III: What Actually Differs
Both are fibrillar collagens built from three polypeptide chains wound into a triple helix, with the characteristic repeating Gly-X-Y sequence. Their roles in skin are different:
Type I collagen
• The dominant structural collagen of adult dermis, roughly 80–85% of dermal collagen.
• Provides tensile strength — resistance to stretching and mechanical support.
• Forms thick, well-organized fibrils and fibers.
• The type most associated in consumers' minds with firm, strong skin.
Type III collagen
• About 10–20% of adult dermal collagen, but far more prominent in fetal skin (reported at roughly 30–60%) and in early wound healing.
• Forms finer, more reticular fibers; historically referred to at the light-microscopy level as "reticulin."
• Associated with suppleness, flexibility, and softness, and with guiding the diameter of assembling collagen fibrils.
• The Type III-to-Type I ratio is high in young/healing tissue and shifts toward Type I as tissue matures and ages.
A useful, buyer-friendly summary: Type I is the framework and strength; Type III is the fine, soft, youthful mesh. This is why many "baby collagen" and post-procedure product stories lean on Type III, while firming and anti-aging lines lean on Type I. In practice, finished products usually feature one type for a focused story rather than an unsupported blend of both.
These proportions are widely reported in dermatology and wound-repair literature; exact percentages vary by source and measurement method, so marketing copy should say "approximately" and avoid false precision.
The Three Official Categories of Recombinant Collagen
The Chinese medical industry standard YY/T 1888-2023 draws a distinction that is very useful for sourcing. When a supplier says "recombinant collagen," ask which of these three they mean, because the words are not interchangeable:
- Recombinant human collagen (rhCol I)
• Contains the full-length amino acid sequence encoded by the human collagen gene.
• The sequence is 100% identical to the human protein, and the product forms the characteristic triple-helix structure.
• The most structurally "complete" category, and the most demanding to produce.
- Recombinant humanized collagen
• Made from the full-length or a partial amino-acid sequence of a specific human collagen type, or a combination containing human collagen functional fragments.
• Has a high degree of sequence identity to human collagen but may be a defined fragment rather than the entire molecule.
• This is the category behind many well-known Type III ingredients and injectable devices.
- Recombinant collagen
• A broader engineered category that may contain designed or composite functional fragments.
• Does not necessarily carry full human sequence identity or the full triple helix.
For an export buyer, the practical question is not just "which type" but "which category and which specific fragment." A defined low-molecular-weight fragment may be chosen for solubility, stability, or formulation handling; a full-length triple-helical protein may be chosen for structural applications. Always get the exact category, the collagen type, the molecular weight, and the purity in writing — don't accept a certificate that says only "collagen."
How Recombinant Collagen Is N